IndiaOne Finance - Company Dashboard

Governance Classic Home

Dishman Carbogen Amcis LtdPharmaceuticalsINE385W01011Consolidated₹170.52+8.41 (+5.19%)Jun-26

Valuation

Market Cap₹2.67K Cr

TTM PE165.55x

Forward PE-40.86x

PEG-1.98

Book Value₹425.87

P/B0.40x

TTM EPS₹1.03

Fwd EPS₹-4.17

TTM Revenue₹2.90K Cr

TTM PAT₹16.16 Cr

TTM EBITDA₹354.82 Cr

TTM EBIT₹91.22 Cr

Last Qtr PAT₹-57.88 Cr

Last Qtr EBITDA₹60.08 Cr

Last Qtr EBIT₹-30.60 Cr

Profitability

ROE0.24%

ROCE1.52%

TTM NPM0.56%

TTM EBITDA %12.23%

Curr OPM-8.32%

Last OPM2.51%

Curr NPM—

Last NPM—

Curr EPS₹-3.69

Last EPS₹1.39

Balance sheet

Equity₹31.36 Cr

Reserve₹6.65K Cr

Total Debt₹3,076.06 Cr

D/E0.46x

Interest %-64.08%

Curr Interest₹37.09 Cr

Price / range

Close₹170.52

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+5.19%

1W+1.96%

1M+0.82%

3M+0.24%

6M-0.40%

1Y-40.38%

2Y-11.78%

3Y+10.58%

5Y-18.43%

Diwali-33.64%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	57.08-9.2%	68.72	39.68	60.30	62.86	231.56
Other Income	18.89	28.83	7.10	11.17	37.42	84.52
Total Income	75.97-24.2%	97.55	46.78	71.47	100.28	316.08
Interest	21.71	22.14	23.51	20.61	20.26	86.52
Expenditure	-105.98-10.2%	-105.03	-81.85	-92.29	-96.16	-375.33
PBDT	0	0	0	0	0	0
EBITDA	-11.82-444.6%	0.98	-3.50	4.41	3.43	5.32
Depreciation	-15.37	-15.15	-15.16	-15.79	-16.47	-62.57
EBIT	-27.19-108.5%	-14.17	-18.66	-11.38	-13.04	-57.25
PBT	-31.70-869.4%	-7.48	-35.07	-20.82	4.12	-59.25
Tax	7.79	3.14	11.94	7.22	-1.45	20.85
Equity	31.36	31.36	0	0	31.36	31.36
OPM	-41.73	-7.67	-88.38	-34.53	4.11	-18.75
Net Profit	-23.91-995.5%	-4.34	-23.13	-13.60	2.67	-38.40
NPM	-31.47	-4.45	-58.29	-22.55	2.66	-12.15
EPS	-1.52-994.1%	-0.28	-1.47	-0.87	0.17	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	231.56-42.1%	399.84+22.1%	327.35-18.7%	402.55+32.9%	302.79+45.6%	208.01
Other Income	84.52	32.98	63.05	52.16	65.71	66.15
Total Income	316.08-27.0%	432.82+10.9%	390.40-14.1%	454.71+23.4%	368.50+34.4%	274.16
Expenditure	-375.33+19.0%	-463.65+5.4%	-490.35+10.7%	-548.91-23.1%	-445.90-0.7%	-442.85
Interest	-86.52	-70.40	-68.19	-57.92	-37.23	-34.17
PBDT	0	0	0	0	0	0
EBITDA	5.32-92.6%	71.79+955.7%	6.80-12.4%	7.76-77.3%	34.19+159.5%	-57.46
Depreciation	-62.57	-65.20	-101.61	-96.20	-140.07	-143.21
EBIT	-57.25-968.7%	6.59+107.0%	-94.81-7.2%	-88.44+16.5%	-105.88+47.2%	-200.67
PBT	-59.25-92.2%	-30.83+70.1%	-103-7.1%	-96.20-15.5%	-83.31+50.6%	-168.69
Tax	20.85	20.96	26.59	37.33	52.84	-64.12
Equity	31.36	31.36	0	0	0	0
OPM (%)	-18.75	-7.12	-26.00	-21.00	-23.00	-62.00
Net Profit	-38.40-289.1%	-9.87+87.1%	-76.41-29.8%	-58.87-86.6%	-31.55+86.4%	-232.81
NPM (%)	-12.15	-2.28	-20.00	-13.00	-9.00	-85.00
EPS (Rs)	0	0+100.0%	-4.87-29.9%	-3.75-86.6%	-2.01+86.5%	-14.85
CEPS	0	0	-4.87	-3.75	-2.01	-14.85

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	677.64-4.3%	851.40	719.80	652.65	708.05	2,931.90
Other Income	18.16	16.42	6.66	8.11	24.75	55.94
Total Income	695.80-5.0%	867.82	726.46	660.76	732.80	2,987.84
Interest	37.09	43.30	0	42.33	42.76	174.18
Expenditure	-745.33-7.8%	-820.54	-736.90	-630.22	-691.48	-2,879.14
PBDT	0	0	0	0	0	0
EBITDA	60.08-57.3%	162.95	-17.10	148.89	140.68	565.63
Depreciation	-90.68	-88.79	0	-84.13	-81.35	-338.69
EBIT	-30.60-151.6%	74.16	-17.10	64.76	59.33	226.94
PBT	-51.22-232.5%	46.13	0	30.54	38.67	104.90
Tax	-6.66	-24.39	-2.53	34.73	-15.26	-7.45
Equity	31.36	31.36	0	0	31.36	31.36
OPM	-7.36	5.32	0.00	4.62	5.28	3.51
Net Profit	-57.88-347.2%	21.74	-12.97	65.27	23.41	97.45
NPM	-8.32	2.51	-1.79	9.88	3.19	3.26
EPS	-3.69-347.7%	1.39	0	4.16	1.49	6.22

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	2,931.90+8.1%	2,711.50+3.7%	2,615.77+8.4%	2,412.92+12.7%	2,140.69+12.0%	1,912.03
Other Income	55.94	21.68	28.21	27.77	43.42	38.45
Total Income	2,987.84+9.3%	2,733.18+3.4%	2,643.98+8.3%	2,440.69+11.7%	2,184.11+12.0%	1,950.48
Expenditure	-2,879.14-6.8%	-2,695.76+2.3%	-2,760.10-12.8%	-2,447.13-12.6%	-2,173.72-9.1%	-1,993.23
Interest	-174.18	-159.46	-119.97	-85.69	-56.81	-47.61
PBDT	0	0	0	0	0	0
EBITDA	565.63+20.6%	468.94+63.7%	286.50-13.8%	332.20+0.3%	331.37+20.8%	274.35
Depreciation	-338.69	-293.74	-310.86	-280.72	-307.59	-307.94
EBIT	226.94+29.5%	175.20+819.2%	-24.36-147.3%	51.48+116.5%	23.78+170.8%	-33.59
PBT	104.90+443.2%	19.31+115.8%	-122.26-124.0%	-54.59-1184.5%	-4.25+93.5%	-65.03
Tax	-7.45	-16.07	-31.19	24.79	22.26	-100.10
Equity	31.36	31.36	0	0	0	0
OPM (%)	3.51	0.71	-4.62	-2.24	-0.19	-3.33
Net Profit	97.45+2907.7%	3.24+102.1%	-153.45-414.9%	-29.80-265.5%	18.01+110.9%	-165.13
NPM (%)	3.26	0.12	-5.80	-1.22	0.82	-8.47
EPS (Rs)	6.22+2861.9%	0.21+102.1%	-9.79-415.3%	-1.90-265.2%	1.15+110.9%	-10.53
CEPS	6.22	0.21	-9.79	-1.90	1.15	-10.53

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2019	Final Dividend	0.2	12 Sep 2019

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split